Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Evaluate whether travel rewards or cash back cards are better for you. Find the card that maximizes your benefits.
26,293 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
SpaceX hovers around $135 ahead of a pivotal Starship test. This report weighs the case for spacex $135: should space...
In early 2026, retirees are increasingly adopting a low-volatility ETF to stabilize portfolios amid ongoing market vo...
SoFi stock fell last month, sparking questions about the growth story and valuation. This article breaks down the fac...
A growing number of couples are missing coordinated claiming strategies, shaving hundreds of dollars from lifetime So...
Global market shifts in 2026 make international exposure a potential anchor for retirement income and diversification...
Analysts issued fresh upgrades on a slate of big-name stocks as earnings season continues. Applied Materials, Devon E...
Trump Mobile says the gold-plated T1 phone will ship this week after nearly year delays, with deposits collected and ...
The bond market is sending a sharp signal to Washington: rising deficits and policy gridlock could raise borrowing co...
Five years into Citi CEO Jane Fraser’s tenure, a sweeping rebuild has shifted the bank from risk and tech bottlenecks...
Micron Technology has surged 93% in the last month on AI data center demand. Investors weigh whether to lock in gains...
A widow learns that the husband died survivor benefit can outpace her own Social Security, prompting urgent planning ...